1345P Intracranial efficacy of brigatinib (BRG) in patients (Pts) with crizotinib (CRZ)-refractory anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) and baseline CNS metastases.
Ou, S-H Tiseo, M Camidge, R Ahn, M Huber, R Hochmair, M Kim, S-W West, H Reckamp, K Molina, J
Ou, S-H
Tiseo, M
Camidge, R
Ahn, M
Huber, R
Hochmair, M
Kim, S-W
West, H
Reckamp, K
Molina, J
Citations
Altmetric:
Abstract
Description
Date
2017-09
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
1345P Intracranial efficacy of brigatinib (BRG) in patients (Pts) with crizotinib (CRZ)-refractory anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) and baseline CNS metastases. 2017, 28(suppl_5): Ann Oncol